Drug Trial Radar · NCT05721573
A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis
Last checked: Nov 19, 2026Latest source record: Oct 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
272
Actual
Start
Feb 28, 2023
Primary completion
Nov 6, 2025
Study completion Nov 27, 2025
Sponsor
- Lead sponsor
- Abcuro, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Syneos Health
- First posted
- Feb 10, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Phase II/III Randomized, Double-blind, Placebo-controlled, Multicenter Study to Determine the Efficacy and Safety of ABC008 in the Treatment of Subjects with Inclusion Body Myositis
Conditions
- Inclusion Body Myositis
Interventions
ABC008Drug
Given by subcutaneous injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part A: Number of Participants With Treatment Emergent Adverse Events (TEAEs)Time frame: Up to Week 80
- Part A: Number of Participants With TEAEs by SeverityTime frame: Up to Week 80
- Part A: Number of Participants With TEAEs Related to Study DrugTime frame: Up to Week 80
- Part A: Mean Change From Baseline in the Inclusion Body Myositis Functional Rating Scale (IBMFRS) Total Score at Week 76Time frame: Baseline (Day 1) and at Week 76
- Part B: Number of Participants With TEAEsTime frame: Day 1 to Week 80
- Part B: Number of Participants With TEAEs by SeverityTime frame: Day 1 to Week 80
- Part B: Number of Participants With TEAEs Related to Study DrugTime frame: Day 1 to Week 80
- Part B: Mean Change From Baseline in the IBMFRS Total Score at Week 76Time frame: Baseline (Day 1) and Up to Week 76
- Part C: Time to PD RecoveryTime frame: Up to Week 24
Locations
45 sites in 7 countries. Site status is shown where the registry gives one.
Neuromuscular Research Center
Phoenix, Arizona
University of California Irvine Medical Center (UCIMC) - Amyotrophic Lateral Sclerosis (ALS) and Neuromuscular Center
Irvine, California
Keck Hosptial of USC
Los Angeles, California
UCLA Medical Center
Los Angeles, California
Stanford Neuroscience Medical Center
Palo Alto, California
University of California, San Francisco
San Francisco, California
University of Colorado Hospital Anschutz Outpatient Pavillion
Aurora, Colorado
Yale School of Medicine
New Haven, Connecticut
Mayo Clinic
Jacksonville, Florida
Northwestern Memorial Hospital, Department of Neurology (Clinic)
Chicago, Illinois
University of Kansas Medical
Kansas City, Kansas
Johns Hopkins Bayview Medical Center
Baltimore, Maryland
Johns Hopkins University School of Medicine
Baltimore, Maryland
Neuromuscular Diagnostic Center - Massachusetts General Hospital
Boston, Massachusetts
Brigham and Womens Hospital
Boston, Massachusetts
Mayo Clinic
Rochester, Minnesota
Washington University School of Medicine
St Louis, Missouri
University of Nebraska Medical Center
Omaha, Nebraska
Hospital for Special Surgery
New York, New York
Columbia University Medical Center / The Neurological Institute of New York
New York, New York
Duke Neurological Disorders Clinic -1L
Durham, North Carolina
Wake Forrest School of Medicine
Winston-Salem, North Carolina
University Hospitals Cleveland Medical Center
Cleveland, Ohio
The Ohio State University Wexner Medical Center
Columbus, Ohio
Oregon Health & Science University
Portland, Oregon
Penn State Health Milton S. Hershey Medical Center
Hershey, Pennsylvania
University of Pennsylvania
Philadelphia, Pennsylvania
UPMC Arthritis and Autoimmunity Center, Falk Clinic
Pittsburgh, Pennsylvania
Austin Neuromuscular Center
Austin, Texas
Texas Neurology
Dallas, Texas
Nerve and Muscle Center of Texas
Houston, Texas
Virginia Commonwealth University
Henrico, Virginia
University of Washington Medical Center - Montlake
Seattle, Washington
Medical College of Wisconsin
Milwaukee, Wisconsin
Royal North Shore Hospital
Saint Leonards, New South Wales, Australia
Royal Brisbane and Women's Hospital
Herston, Queensland, Australia
Perron Institute for Neurological and Translational Science
Nedlands, Western Australia, Australia
AZ Sint-Lucas & Volkskliniek
Ghent, Belgium
Heritage Medical Research Clinic - University of Calgary
Calgary, Alberta, Canada
Genge Partners Inc.
Montreal, Quebec, Canada
Showing 40 of 45 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.